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Abstract  Young  adults  with  attention  deﬁcit  hyperactivity  disorder  (ADHD)  are  at  high  risk
of substance  use  (SU).  The  aims  of  the  current  study  were:  1)  to  examine  the  use  of  alcohol,
tobacco, marijuana  and  other  illegal  drugs  by  adults  with  and  without  ADHD;  2)  to  compare
the oppositional,  conduct,  anxiety,  depression,  sleep  and  antisocial  personality  symptoms  of
ADHD adults  with  SU  and  ADHD  adults  without  SU;  3)  to  examine  the  ability  of  ADHD  symptoms
and conduct  problems  to  predict  SU.  A  total  of  93  young  adults,  43  without  ADHD  and  50
with a  childhood  diagnosis  of  ADHD,  who  were  part  of  the  Spanish  sample  of  the  Multicenter
ADHD Genetics  (IMAGE)  study,  collaborated  in  a  follow-up  evaluation  10.1  years  later.  ADHD
participants  were  divided  into  two  groups  based  on  the  presence  or  absence  of  SU.  Statistically
signiﬁcant  differences  were  found  between  young  adults  with  and  without  ADHD  in  their  use  of
tobacco, marijuana  and  alcohol.  A  statistically  signiﬁcant  association  was  also  shown  between
externalization  problems  and  a  greater  risk  of  SU.  Conduct  problems,  to  a  greater  degree  than
ADHD symptoms,  affect  SU  in  ADHD  adults.
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Consumo  de  sustancias  en  jóvenes  adultos  con  TDAH:  comorbilidad  y  síntomas  de
inatención  e  hiperactividad/impulsividad
Resumen  Los  jóvenes  con  trastorno  por  déﬁcit  de  atención  con  hiperactividad  (TDAH)  tienen
un elevado  riesgo  de  uso  de  sustancias  (US).  Los  objetivos  del  presente  trabajo  fueron:  1)
analizar el  consumo  de  alcohol,  tabaco,  marihuana  y  otras  drogas  ilegales  en  adultos  con  y
sin TDAH;  2)  comparar  a  los  adultos  con  TDAH  con  y  sin  US  en  oposicionismo,  problemas  de
conducta,  ansiedad,  depresión,  suen˜o  y  personalidad  antisocial;  3)  determinar  la  capacidad  de
la sintomatología  de  TDAH  y  de  los  problemas  de  conducta  para  predecir  el  US.  Noventa  y  tres
jóvenes adultos,  43  sin  TDAH  y  50  con  diagnóstico  de  TDAH  en  la  infancia  que  participaron  en
el estudio  Multicenter  ADHD  Genetics  (IMAGE)  colaboraron  en  una  evaluación  de  seguimiento
10.1 an˜os  después.  Los  participantes  con  TDAH  se  dividieron  en  dos  subgrupos  según  presencia
o ausencia  de  US.  Los  jóvenes  con  y  sin  TDAH  se  diferenciaron  signiﬁcativamente  en  consumo
de tabaco,  marihuana  y  alcohol.  Se  constató  una  relación  signiﬁcativa  entre  los  trastornos  de
conducta  y  US  en  adultos  TDAH.  Los  problemas  de  conducta  más  que  los  síntomas  de  TDAH
inﬂuyen en  el  US  de  adultos  con  TDAH.
© 2015  Asociación  Espan˜ola  de  Psicología  Conductual.  Publicado  por  Elsevier  España,  S.L.U.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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cThe  accumulated  research  has  shown  that  attention
eﬁcit  hyperactivity  disorder  (ADHD)  symptoms  extend
hroughout  life  in  up  to  60%  of  the  cases  (Willcutt,  2012).
heir  persistence  has  been  associated  with  functional
mpairment  in  psychosocial,  educational,  professional  and
amily  functioning  (Biederman,  Petty,  Woodworth  et  al.,
012).  In  addition,  compared  to  adults  without  ADHD,  adults
ith  ADHD  experience  higher  levels  of  anxiety  disorders,
ood  disorders,  conduct  disorders  and  antisocial  person-
lity  disorder  (Hesson  &  Fowler,  2015;  Miranda,  Berenguer,
olomer,  &  Roselló,  2014;  Nogueira  et  al.,  2014),  as  well  as
n  increased  risk  of  abuse/dependence  on  nicotine,  alco-
ol,  marijuana,  cocaine,  and  other  unspeciﬁed  substances
Breyer,  Lee,  Winters,  August,  &  Realmuto,  2014;  van
mmerik-van  Oortmerssen  et  al.,  2012).  Of  the  core  ADHD
ymptoms,  hyperactivity/impulsivity  generally  shows  more
obust  and  consistent  relations  with  dependence  on  various
llicit  substances  than  inattention  which  has  only  been  asso-
iated  with  alcohol  use  (Capusan,  Bendtsen,  Marteinsdottir,
uja-Halkola,  &  Larsson,  2015;  Roberts,  Peters,  Adams,
ynam,  &  Milich,  2014).
In  addition,  the  strength  of  the  association  between
ubstance  use  (SU)  and  ADHD  varies.  Thus,  among  adoles-
ents  with  ADHD,  about  19%-46%  smoke  cigarettes,  whereas
nly  10--24%  of  non-ADHD  individuals  smoke  (Burke,  Loeber,
hite,  Stouthamer-Loeber,  &  Pardini,  2007).  Moreover,
igarette  smoking  is  a  risk  factor  for  other  substance  mis-
se.  In  fact,  adolescents  with  ADHD  are  4  to  5  times  more
ikely  than  controls  to  escalate  to  heavy  cigarette  and  mar-
juana  use  after  trying  these  substances  once  (Biederman,
etty,  Hammerness,  Batchelder,  &  Faraone,  2012).
Another  interesting  issue  is  the  analysis  of  the  inﬂuence
f  other  psychopathologies,  including  comorbid  external-
zing  and  internalizing  problems,  in  predicting  substance
buse/dependence.  Some  ﬁndings  indicate  that  conduct
isorder  (CD)  and  oppositional  deﬁant  disorder  (ODD)  are
ositively  associated  with  SU  in  ADHD  subjects.  Thus,
d
a
tymmes  et  al.  (2015)  compared  nicotine  use  throughout
oung  adulthood  in  three  groups,  based  on  childhood  status:
DHD  only,  ADHD  externalizers  and  control  groups.  Results
ndicated  that  at  all  three  data  collection  points,  individuals
ith  childhood  ADHD  plus  an  externalizing  disorder  reported
igher  nicotine  use  compared  to  the  ADHD  group  without
n  externalizing  disorder  and  the  comparison  group  of  non-
DHD  youth.  The  group  differences  were  signiﬁcant,  even
fter  controlling  for  possible  confounding  variables  (age,
ender,  and  current  treatment  with  psychostimulant  med-
cation).
Along  the  same  lines,  Brinkman,  Epstein,  Auinger,
amm  and  Froehlich  (2015)  found  that  adolescents  with
n  ADHD+CD  diagnosis  had  a  3-  to  5-fold  increase  in
he  likelihood  of  using  tobacco  and  alcohol,  and  initi-
ted  use  at  a  younger  age,  compared  to  those  with
either  disorder.  Having  ADHD  alone  was  associated  with
n  increased  likelihood  of  tobacco  use,  but  not  alcohol
se.  Hyperactivity-impulsivity  symptom  counts  were  not
ndependently  associated  with  any  outcome,  while  every
ymptom  increase  in  inattention  increased  the  likelihood  of
obacco  and  alcohol  use  by  8-10%.
A  meta-analysis  by  Serra-Pinheiro  et  al.  (2013)  also  con-
luded  that  the  risk  of  SU  in  individuals  with  ADHD  could
e  explained  to  a  large  degree  by  the  frequent  presence  of
DD  and  CD.  However,  some  studies  have  shown  a  direct  link
etween  ADHD  and  SU,  even  when  CD  is  controlled  (Arias
t  al.,  2008),  so  that  ADHD  would  be  an  independent  risk
actor  for  substance  use  disorder,  although  the  ADHD+CD
ombination  would  increase  the  risk.
Less  attention  has  been  devoted  to  research  on  the
ontribution  of  mood  or  anxiety  disorders  to  substance  dis-
rder  vulnerability  in  ADHD.  The  systematic  examination
arried  out  by  Wilens  and  colleagues  (2011)  concluded  that,
espite  relatively  high  rates  of  major  depressive  (42%-52%)
nd  anxiety  (23%-24%)  disorders  at  baseline  (ages  6-17),  nei-
her  of  these  comorbidities  predicted  the  overall  category
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PSubstance  use  in  young  adults  with  ADHD  
of  SU  at  the  10-year  follow-up.  In  fact,  mood  disorders  pre-
dicted  drug-use  disorders,  but  not  overall  SU,  alcohol  use
disorders,  or  cigarette  smoking.  These  ﬁndings  partly  sup-
ported  the  idea  that  depression  was  not  associated  with
SU.
The  purpose  of  this  study  is  to  increase  the  knowledge
about  ADHD  when  it  co-exists  with  addictive  behaviors  that
have  an  impact  on  the  lives  of  the  individuals  affected
and  the  people  around  them.  Despite  a  growing  body  of
literature,  it  is  necessary  to  identify  more  precisely  the
substances  consumed  by  adults  with  a  childhood  diagnosis
of  ADHD  combined-subtype  and  explore  the  relationship  of
these  use  patterns  with  the  comorbidities  associated  with
the  disorder.  The  speciﬁc  aims  of  the  current  study  were:
1)  To  determine  the  use  of  alcohol,  tobacco,  marijuana
and  other  illegal  drugs  in  adults  with  ADHD  compared
to  adults  without  ADHD  (no  ADHD).
2)  To  compare  adults  with  ADHD  plus  SU  and  adults  with
ADHD  without  SU  on  problems  commonly  associated
with  the  disorder,  that  is,  oppositional  deﬁant  disorder,
conduct  disorder,  anxiety  disorder,  depression,  sleep  dis-
order,  and  antisocial  personality  disorder.
3)  To  investigate  the  capacity  of  ADHD  symptoms  and  exter-
nalizing  problems  (ODD  and  CD)  symptoms  to  predict  the
use  of  alcohol,  tobacco,  marijuana  and  other  illegal  drugs
in  adults  with  ADHD.
We  predicted  that  the  prevalence  of  SU  in  ADHD  young
adults  would  be  higher  than  in  the  comparison  group.
We  also  predicted  that  ADHD  young  adults  with  SU  could
experience  more  mental  disorders  than  ADHD  young  adults
without  SU.  Finally,  we  hypothesized  that  ADHD  symptoms
co-occurring  with  CD  and  ODD  would  be  associated  with  a
greater  risk  of  SU.
Method
Participants
The  sample  was  composed  of  93  young  adults,  43  with-
out  ADHD  (no  ADHD)  and  50  with  ADHD,  who  were  part
of  the  Spanish  sample  of  the  Multicenter  ADHD  Genetics
(IMAGE)  study.  When  the  ADHD  participants  were  ﬁrst  evalu-
ated  between  2003  and  2006,  were  between  5  and  16  years
old  and  presented  a  clinical  diagnosis  of  ADHD  combined-
subtype,  according  the  international  diagnostic  criteria  for
this  subtype  from  the  revised  fourth  edition  of  the  Diagnos-
tic  and  Statistical  Manual  of  Mental  Disorders  (DSM-IV-TR;
American  Psychiatric  Association,  APA,  2000) (see  descrip-
tion  of  the  sample  in  Müller  et  al.,  2011).  Fifty  of  81  subjects
from  original  sample  of  IMAGE  study  participated  in  the
current  follow-up  evaluation,  which  took  place  on  average
10.1  years  later,  between  2013  and  2015.  Fourteen  subjects
(17%)  did  not  participate  because  of  loss  of  their  localiza-
tion  (changes  in  the  family  address  or  contact  telephone),  7
participants  declined  to  attend  to  the  evaluations  (9%),  and
10  participants  were  less  than  17  years  old  (12%).
The  ADHD  group  had  between  17  and  24  years
(M  =  18.7,  SD  =  1.4)  and  had  an  IQ  between  the  normal
range  (M  =  104.21,  SD  =  15.41).  Additionally,  65%  of  these
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articipants  according  to  the  subjects  themselves  and  60%
ccording  to  the  observer  had  5  or  more  ADHD  symptoms
f  inattention  and/or  hyperactivity/impulsivity  considering
he  5  symptoms  cut-off  based  on  the  recent  version  of  the
SM  (DSM-5;  APA,  2013) criteria  for  ADHD  in  adults.
The  43  participants  without  ADHD  were  not  part  of  the
revious  sample  and  they  were  selected  according  to  the  cri-
eria  of  the  National  Institute  of  Statistics  of  Spain  for  the
istribution  of  the  population,  based  on  their  grade  level
nd  employment  status  in  the  age  range  of  17-24  years.
e  contacted  these  individuals  by  disseminating  information
bout  this  research  project  in  Universities,  vocational  train-
ng  schools,  and  secondary  schools  and  their  participation
as  voluntary.  They  also  had  to  meet  the  following  crite-
ia:  1)  No  history  of  signiﬁcant  problems  of  inattention  or
yperactivity  /  impulsivity;  2)  T  scores  below  65  on  both  the
SM-IV  inattention  and  hyperactivity/impulsivity  subscales
f  the  CAARS  observer  and  self-report  versions;  3)  Absence
f  neurological  disorders,  sensory  or  motor  deﬁcits  (paraly-
is,  deafness,  blindness),  autism  or  psychosis;  and  4)  an  IQ
qual  to  or  greater  than  70.  Eight  participants  were  removed
or  meeting  5  or  more  symptoms  of  inattention  or  hyperac-
ivity/impulsivity  according  to  the  DSM-5  criteria.  The  group
ithout  ADHD  had  a  mean  age  of  19.26  (SD  =  1.83)  and  a
ean  IQ  of  103.02  (SD  =  11.57)  (see  Table  1).
The  two  groups,  with  ADHD  and  no  ADHD,  were  matched
or  age,  t  (91)  =  -  1.56,  p  =  .121  and  sex,  2 (1,  N  =  93)  = .208,
 =  .649,  with  96.8%  being  males.  The  difference  between
he  two  groups  in  estimated  IQ,  using  the  vocabulary  and
lock  design  tests  from  the  Wechsler  Adult  Intelligence  Scale
WAIS  III;  Wechsler,  1999),  was  not  signiﬁcant,  t  (91)  =  .42,
 =  .679.
Parents  and  participants  reported  drinking  alcohol  or
onsumption  of  tobacco,  marijuana  and  other  illegal  drugs
e.g.,  cocaine,  ecstasy,  opiates,  etc.)  in  the  previous  twelve
onths.  This  information  was  adopted  as  the  criterion  for
plitting  ADHD  participants  into  two  groups:  a  group  with
ubstance  use  (ADHD-SU)  and  a  group  without  substance  use
r  with  low  risk  of  substance  use  (ADHD-N/SU).  We  classiﬁed
 participant  in  the  former  group  when  either  he  or  his  par-
nts  reported:  1)  frequent  consumption  (2  drinks  per  day)  or
ery  frequent  alcohol  consumption  (more  than  2  drinks  per
ay  or  more  than  4  during  the  week);  2)  any  amount  of  smok-
ng  daily;  3)  marijuana  at  least  once  a  week;  or  4)  occasional
se  (at  least  once  a  month)  of  other  illegal  drugs,  such  as
ocaine,  heroin  and  opiates.  A  subject  was  classiﬁed  in  the
atter  group  if  both  he  and  his  parents  reported  that  there
as  no  SU  or  only  very  occasional  consumption  of  alcohol  or
obacco  (e.g.,  at  parties  or  other  special  occasions).
By  dividing  the  ADHD  group  into  two  groups,  one  with
U  and  one  without  it,  statistically  signiﬁcant  differences  in
ge  were  found  (F (2,90) =  4.36,  p  =  .016);  therefore,  age  was
ntroduced  in  the  analysis  as  a covariate.
easures
resence  and  severity  of  ADHD  symptomshe  presence  and  severity  of  ADHD  symptoms  was  eval-
ated  with  the  long  version  of  the  Conners  Adult  ADHD
ating  Scale-Observer  version  (CAARS;  Conners,  Erhardt,
160  A.  Miranda  et  al.
Table  1  Sociodemographic  characteristics.
ADHD-SU  (n  =  27)  ADHD-N/SU  (n  =  23)  no  ADHD  (n  =  43)  Statistic
M  SD  M  SD  M  SD  F (2, 90) p
Age 19.22  1.60  18.13  0.81  19.26  1.83  4.36  .016
IQ 102.19  14.93  106.59  15.96  103.02  11.57  0.72  .488
N %  N  %  N  %  2 p
%  Male 26  96.3  22  95.7  42  97.7  0.22  .894
Medication (%) .71 .400
Previous  or  current  medication 20  74.1  20  86.9  -  -
No medication 7  25.9  3  13.1  -  -
Parental employment  (%)  5.05  .282
Skilled job  13  50  7  30.4  17  44.7
Unskilled job  8  30.8  9  39.2  17  44.7
Unemployed  5  19.2  7  30.4  4  10.6
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pNote. ADHD-SU = ADHD with substance use; ADHD-N/SU = ADHD with
 Sparrow,  1999),  which  consists  of  66  items  divided  into
ine  subscales.  It  includes  the  18  ADHD  symptoms  from
he  DSM-IV,  measured  on  a  4-point  Likert-type  scale  and
rouped  in  two  subscales:  DSM-IV-Inattention  and  DSM-
V-Hyperactivity/  impulsivity.  The  T-scores  of  these  two
ubscales  were  used  as  dependent  variables  in  this  study.  T-
cores  greater  than  or  equal  to  65  were  considered  clinically
igniﬁcant.  DSM-IV-Inattention  subscale  difﬁculties  include
rouble  concentrating,  difﬁculty  planning  or  completing
asks,  forgetfulness,  absent-mindedness,  and  being  disorga-
ized.  The  hyperactivity/impulsivity  subscale  includes  items
elated  to  problems  with  working  on  the  same  task  for  long
eriods  of  time,  feeling  more  restless  than  others  seem  to
e,  and  ﬁdgeting.  This  instrument  has  satisfactory  reliability
nd  validity.  Internal  reliability  of  the  factor  scales  ranged
rom  .86  to  .92;  test-retest  reliabilities  ranged  from  .88  to
91  (Erhardt,  Epstein,  Conners,  Parker,  &  Sitarenios,  1999).
resence  and  severity  of  comorbidity  symptoms
uestionnaire  on  Comorbidity-Weiss  Symptom  Record  (WSR;
eiss,  2010).  This  clinical  screening  questionnaire  is  not
sychometrically  validated  but  is  based  on  the  DSM-IV-TR
riteria  (APA,  2000).  Although  it  is  not  a  diagnostic  scale,
t  serves  the  useful  purpose  to  identify  adult  mental  dis-
rders  by  collecting  information  about  Axis  I  and  Axis  II
ental  disorders  in  any  age  group  and  from  any  informant.
n  this  research  was  use  the  subscales  used  were  Opositional
eﬁant  Disorder  (ODD),  Conduct  Disorder  (CD),  Anxiety,
epression,  Sleep  Disorder,  and  Antisocial  Personality  Dis-
rder.  The  items  have  different  response  options;  ‘‘0-Not  at
ll’’,  ‘‘1-somewhat’’,  ‘‘2-pretty  much’’  and  ‘‘3-very  much’’
usually  interpreted  as  ‘‘this  is  a  problem  that  causes  great
ifﬁculty’’).  A  sum  of  the  score  on  each  item  of  the  disor-
ers  mentioned  above  was  used  as  dependent  variable  in  the
nalysis  dichotomized  as  ‘‘absence’’(0,  1)  or  ‘‘presence’’
2,  3).  To  evaluate  clinical  information  about  the  pattern  of
U,  both  the  parents  and  young  adults  ﬁlled  out  the  WSR
ubscale  for  Substance  Use  Disorder.  This  subscale  is  com-
osed  of  5 items  about  the  consumption  of  alcohol,  tobacco,
arijuana  and  other  street  drugs,  as  well  as  the  abuse  of
rescription  drugs.  In  the  current  study,  we  did  not  use
n
f
p
eubstance use; no ADHD = Without ADHD; IQ = Intelectual quocient.
‘abuse  of  prescription  drugs’’  because  none  of  the  parti-
ipants  used  these  drugs.
rocedure
n  the  current  study,  the  Weiss  comorbidity  questionnaire
o  evaluate  the  clinical  information  on  manifestations  of
sychopathologies  was  ﬁlled  out  by  adults  with  ADHD  and
dults  without  ADHD.  In  addition,  parents  or  a  family  mem-
er  of  the  ADHD  group  participants  completed  the  CAARS
cale  adult  ADHD-observer  version  to  assess  the  presence
nd  severity  of  symptoms  of  inattention  and  hyperactivity  /
mpulsivity.  The  assessment  was  performed  by  ADHD  experts
rained  in  the  administration  and  rating  of  the  interviews
nd  questionnaires  used.  Evaluators  strictly  followed  the
ame  method  to  apply  and  correct  assessment  test.  All  the
articipants  gave  their  written  consent  after  being  informed
f  the  study  goals  and  funding.  They  were  given  30  Euros  for
heir  participation.
tatistical analyses
nalyses  were  conducted  using  IBM  SPSS  Statistics,  ver-
ion  21.0  (SPSS  Inc.,  Chicago,  IL,  USA).  Chi-square  (2)
nalyses  were  conducted  to  test  group  differences  in  SU
etween  adults  with  and  without  ADHD.  A  multivariate
nalysis  of  covariance  (MANCOVA)  was  used  to  study  dif-
erences  in  the  comorbid  problems  of  ADHD  adults  with
nd  without  SU.  For  this  purpose,  ADHD  substance  use  sta-
us  (ADHD-SU,  ADHD-N/SU)  was  used  as  the  ﬁxed  factor,
nd  symptoms  of  comorbid  problems  (ODD,  CD,  anxiety,
epression,  sleep  disorder,  and  antisocial  personality  disor-
er)  were  used  as  dependent  variables.  Age  was  included
n  the  model  as  a  covariate.  Given  the  signiﬁcant  main
ffect  in  the  MANCOVA  model,  individual  tests  of  between-
ubject  effects  were  examined  to  identify  which  comorbid
roblems  signiﬁcantly  differed  by  group.  The  level  of  sig-
iﬁcance  was  set  at  .008,  after  using  Bonferroni  correction
or  multiple  comparisons.  Effect  sizes  were  calculated  using
artial  Eta  squared  values  (according  to  Cohen  (1988):
ta  squared,  .06  =  small;  .06-.14  =  medium,  .14  =  large  effect
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0 20 40 60
Loses temper
Argues with adults
Deliberately annoys people
Touchy or easily annoyed by others % ADHD SU 
% ADHD N/SU 
Figure  1  Percentage  of  presence  of  speciﬁc  ODD  symptoms  in
ADHD adults  with  and  without  substance  use.  ADHD-SU  =  ADHD
with substance  use;  ADHD-N/SU  =  ADHD  without  substance  use;
ODD =  Oppositional  deﬁant  disorder.
0 10  20  30  40  50  60 
Bullies, threatens, or intimidates others
Broken into a house, building, or car
Often lies to obtain goods or benefits or
avoid obligations   
Stealing items of nontrivial value without
confronting victim  
% ADHD SU 
% ADHD N/SU 
Figure  2  Percentage  of  presence  of  speciﬁc  CD  symptoms  in
ADHD adults  with  and  without  substance  use.  ADHD-SU  =  ADHD
with substance  use;  ADHD-N/SU  =  ADHD  without  substance  use;
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size).  In  addition,  some  ODD  and  CD  symptoms  were  cate-
gorized  as  ‘‘presence/absence’’.  Chi-square  analyses  were
conducted  to  test  for  differences  between  ADHD  adults  with
and  without  SU  in  the  proportion  of  participants  classiﬁed  as
‘‘presence’’  for  each  comorbid  symptom.  Finally,  to  inves-
tigate  which  symptoms  (ADHD  or  conduct  problems)  best
predicted  substance  use  (alcohol,  tobacco,  marijuana,  other
illegal  drugs),  binomial  logistic  regression  analysis  was  per-
formed.  The  data  were  entered  into  the  logistic  regression
model  in  three  blocks:  Block  1  -  age;  Block  2  --  ODD  and  CD
symptoms  (continuous  variables);  and  Block  3:  ADHD  inat-
tention  and  hyperactivity/impulsivity  symptoms  (continuous
variables).  The  ORs,  95%  conﬁdence  intervals  and  the  R2
value  (Nagelkerke-adjusted  value)  for  the  overall  models  are
reported.
Results
Substance  use  in adults  with  and  without  ADHD
The  ﬁrst  aim  of  this  study  was  to  compare  the  SU  of
young  adults  with  and  without  ADHD.  Chi-square  analy-
sis  showed  statistically  signiﬁcant  differences  between  the
groups  in  the  use  of  alcohol  [2 (1,  N  =  93)  =  5.91,  p  =  .015],
tobacco  [2 (1,  N  =  93)  =  10.22,  p  =  .001]  and  marijuana  [2
(1,  N  =  93)  =  7.79,  p  =  .005].  In  all  cases,  SU  percentages  were
higher  in  the  ADHD  group  than  in  the  no  ADHD  group.  Differ-
ences  in  other  illegal  drugs,  like  cocaine  or  opiates,  did  not
reach  statistical  signiﬁcance  [2 (1,  N  =  93)  =  .250,  p  =  .114]
(see  Table  2).
Comparison  of  comorbidities  between  ADHD  groups
with and  without  substance  use
Table  3  shows  that  54%  (n  =  27)  of  ADHD  adults  consumed
some  kind  of  substance  (ADHD-SU  group)  versus  46%  (n  =  23)
who  did  not  (ADHD-N/SU  group).  Comorbid  problem  symp-
tomatology  in  the  two  ADHD  groups  (with  and  without
SU)  was  compared.  MANCOVA  results  revealed  statisti-
cally  signiﬁcant  differences  [Wilks’  Lambda  ()  =  .69,  F  (6,
42)  =  3.07,  p  =  .014,  2p =  .305].  ANCOVA  results  indicated
statistically  signiﬁcant  differences  for  ODD  and  CD.  In  both
cases,  the  ADHD-SU  group  presented  signiﬁcantly  higher
comorbidity  scores  than  the  ADHD-  N/SU  group.  However,
ADHD-SU  and  ADHD-  N/SU  did  not  differ  signiﬁcantly  on
anxiety,  depression,  sleep  disorder,  or  antisocial  personality
disorder  (see  Table  3).
Next,  an  analysis  was  performed  of  possible  differ-
ences  in  ODD  and  CD  manifestations  in  the  two  groups
of  subjects  with  ADHD.  Speciﬁcally,  there  were  sta-
tistically  signiﬁcant  differences  between  ADHD  adults
with  and  without  SU  on  some  speciﬁc  ODD  symptoms,
such  as  ‘‘Touchy  or  easily  annoyed  by  others’’  [2 (1,
N  =  50)  =  4.30,  p  =  .030];  ‘‘Deliberately  annoys  people’’  [2
(1,  N  =  50)  =  7.03,  p  =  .008];  ‘‘Argues  with  adults’’  [2
(1,  N  =  50)  =  4.72,  p  =  .030]  and  ‘‘Loses  temper’’  [2 (1,
N  =  50)  =  4.78,  p  =  .029].  There  were  no  signiﬁcant  differ-
ences  in  the  other  ODD  manifestations  (see  Figure  1).
There  were  also  differences  between  the  groups  in  some
speciﬁc  CD  symptoms:  ‘‘Stealing  items  of  nontrivial  value
without  confronting  victim’’  [2 (1,  N  =  50)  = 5.81,  p  = .016];
i
t
m
aD =  Conduct  Disorder.
‘Often  lies  to  obtain  goods  or  beneﬁts  or  avoid  obliga-
ions’’  [2 (1,  N  =  50)  =  4.71,  p  =  .030];  ‘‘Broken  into  a  house,
uilding,  or  car’’  [2 (1,  N  =  50)  =  3.78,  p  =  .05];  ‘‘Bullies,
hreatens,  or  intimidates  others’’  [2 (1,  N  =  50)  =  3.79,
 =  .05]  (See  Figure  2).
elationship  between  ADHD  symptoms,
xternalizing  problems  (ODD  and  CD)  and
ubstance use
ogistic  regression  analyses  were  conducted  to  examine  the
elationships  among  ADHD  symptoms,  externalizing  prob-
ems  (ODD  and  CD)  and  the  risk  of  SU  (see  Table  4).  The
nal  models,  where  age,  ADHD  symptoms  and  external-
zing  problems  were  introduced,  explained  21.2%,  31.5%,
4.3%  and  49.6%  of  the  variances  in  alcohol,  tobacco,  mari-
uana  use  and  illegal  drug  use,  respectively.  These  analyses
evealed  that  neither  ADHD  symptoms  nor  conduct  prob-
ems  were  associated  with  alcohol  or  tobacco  use.  The  only
ariable  that  signiﬁcantly  distinguished  the  SU  groups  was
onduct  disorder,  which  was  associated  with  both  marijuana
se  (p  =  .038;  OR  =  1.45;  CI  =  1.02-2.07)  and  the  use  of  other
llegal  drugs  (p  =  .007;  OR  =  1.95;  CI  =  1.20-3.16).  ADHD  symp-
oms  did  not  contribute  signiﬁcantly  to  any  of  the  four  ﬁnal
odels;  although  inattention  had  a nearly  signiﬁcant  associ-
tion  with  marijuana  use  (p  =  .056;  OR  =  1.09;  CI  =  0.99-1.19).
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Table  2  Differences  in  substance  use  between  adults  with  and  without  ADHD.
ADHD  (n  =  50)  No  ADHD  (n  =  43)  Statistic
Substance  use  (SU)  N  %  N  %  2(1, N=  93) p
Alcohol  9  18  1  2.3  5.92  .015*
Tobacco  19  38  4  9.3  10.23  .001*
Marijuana  20  40  6  14  7.79  .005*
Other  illegal  drugs  9  18  3  7  2.50  .114
* p < .05
Table  3  Differences  in  comorbid  problems  between  ADHD  adults  with  and  without  substance  use.
ADHD  SU  (n  =  27)  ADHD  N/SU  (n  =  23)  Statistic
Comorbidities  M  SD  M  SD  F (1,47) p  2P
ODD  8.19  4.45  4.48  2.66  11.57  .001*  .198
CD 6.41  4.30  2.09  1.75  14.18  000*  .232
Anxiety 2.52  2.17  3.13  2.75  0.18  .672  .004
Depression 3.44  3.22  2.57  4.39  0.73  .395  .015
Sleep Disorder 1.78  2.04  2.70  3.03  1.50  .226  .031
Antisocial P. .37 .63  .09  .28  1.63  .208  .034
Note. ADHD-SU = ADHD with substance use; ADHD-N/SU = ADHD without substance use ODD = Oppositional deﬁant disorder; CD = Conduct
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Tdisorder; Antisocial P. = Antisocial personality disorder. *p < .008 
comparisons).
iscussion
he  ﬁrst  objective  of  the  current  study  was  to  conﬁrm  that
hildren  with  ADHD  combined-type  have  an  increased  risk  of
U  in  young  adulthood.  Coinciding  with  a  large  body  of  lit-
rature,  we  found  a  signiﬁcantly  higher  prevalence  of  SU  in
he  group  with  ADHD  compared  to  the  group  without  ADHD
Breyer  et  al.,  2014;  van  Emmerik-van  Oortmerssen  et  al.,
012),  according  to  our  prediction:  alcohol,  tobacco  and
arijuana.  Only  the  rates  of  use  of  illicit  drugs  other  than
arijuana  were  not  signiﬁcantly  different  from  the  control
roup  although  they  were  high.
In  fact,  with  regard  to  illegal  drugs,  the  40%  of  the
articipants  with  ADHD  had  used  marijuana,  versus  14%
f  the  group  without  ADHD,  which  matches  the  percent-
ge  provided  by  the  OEDT  (14%  for  young  people  between
5  and  24  years  old).  Various  mechanisms  could  be  oper-
ting  in  the  overrepresentation  of  SU  identiﬁed  in  this
ample,  such  as  a  common  genetic  predisposition  between
DHD  and  SU.  Particularly  regarding  dependence  on  alcohol
Edwards  &  Kendler,  2012)  some  data  suggest  that  shared
enetic  risk  factors  explain  64%  of  the  overlap  between
DHD  and  alcohol  (Capusan  et  al.,  2015).  Self-medication
f  ADHD  symptoms  and  personality  factors,  such  as  impul-
ivity,  anger  or  high  levels  of  sensation  seeking,  are  other
ossible  explanations  proposed  for  the  propensity  of  SU  in
eople  with  ADHD  (Arias  et  al.,  2008;  Ballon,  Brunault,  &
ortese,  2015).  There  are  also  diverse  psychosocial  factors,
ncluding  academic  failure,  social  problems  or  a  permissive
nd  tolerant  parenting  style  (Cerezo,  Méndez,  &  Ato,  2013;
ortese  et  al.,  2015;  Molina  &  Pelham,  2014).
According  to  the  results,  our  second  prediction  was  par-
ially  conﬁrmed.  ADHD-SU  and  ADHD-  N/SU  groups  did  not
s
e
a
Perroni correction of critical p values when performing multiple
iffer  signiﬁcantly  on  anxiety,  depression  or  sleep  disor-
er  symptoms  (Wilens  et  al.,  2011).  However,  supporting
ur  hypothesis,  the  ADHD-SU  group  presented  signiﬁcan-
ly  higher  comorbidity  scores  than  the  ADHD-  N/SU  group
n  externalizing  disorders.  As  in  other  studies  (Brinkman
t  al.,  2015;  Nogueira  et  al.,  2014;  Symmes  et  al.,  2015),
he  manifestations  of  ODD  and  CD  in  individuals  with  child-
ood  ADHD  and  SU  were  clearly  more  prevalent  than  in  the
DHD  group  that  did  not  consume.  More  speciﬁcally,  there
ere  statistically  signiﬁcant  differences  in  ODD  symptoms
f  irritability,  such  as  ‘‘Touchy  or  easily  annoyed  by  oth-
rs’’  and  ‘‘Loses  temper’’,  or  headstrong  behaviors,  such  as
‘Deliberately  annoys  people’’  and  ‘‘Argues  with  adults’’.
here  were  also  differences  between  the  groups  in  some
peciﬁc  CD  symptoms  related  to  deceitfulness  or  theft,  such
s  ‘‘Stealing  items  of  nontrivial  value  without  confronting
he  victim’’  and  ‘‘Often  lies  to  obtain  goods  or  beneﬁts  or
void  obligations’’,  in  non-aggressive  manifestations  of  CD,
‘Broken  into  a  house,  building,  or  car’’,  and  on  an  item
elated  to  aggression  toward  people,  ‘‘Bullies,  threatens,
r  intimidates  others’’.
Finally,  concerning  our  third  prediction,  neither  ADHD
ymptoms  severity  nor  externalizing  problems  were  asso-
iated  with  alcohol  or  tobacco  use  in  the  ADHD  adults.
owever,  the  manifestations  of  conduct  disorder  signiﬁcan-
ly  predicted  both  the  use  of  marihuana  and  the  use  of
ther  illegal  drugs.  Of  the  ADHD  symptoms,  only  inatten-
ion  had  a  nearly  signiﬁcant  association  with  marijuana  use.
hese  results  suggest  that  CD  symptoms,  rather  than  ADHD
ymptoms,  are  the  strongest  predictor  of  substance  use,
specially  more  severe  drugs  like  marijuana  and  cocaine,
ccording  with  several  studies  (Rodgers  et  al.,  2015;  Serra-
inheiro  et  al.,  2013).
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Table  4  Logistic  regression  analyses  of  predictors  of  use  of  tobacco,  alcohol,  marijuana  and  other  illicit  drugs.
Block  1  --  Age  Block  2  --
Externalizing  problems
Block  3  --  ADHD  symptoms
OR  95%  CI  OR  95%  CI  OR  95%  CI
Alcohol
Constant  0† 0† 0
Age  1.44  0.92-2.28  1.34  0.82-2.18  1.35  0.81-2.24
Inattention 0.95  0.87-1.03  0.95  0.87-1.04
Hyperactivity/Imp.  1.07  0.99-1.15  1.05  0.97-1.14
ODD 1.05  0.82-1.35
Conduct Disorder  1.06  0.80-1.41
Nagelkerke  R2 0.080  0.18  .21
Tobacco
Constant  0*  0†  0†
Age 1.69†  0.98-2.92  1.67†  0.96-2.92  1.58  0.08-2.91
Inattention 1  0.94-1.08  1.01  0.93-1.09
Hyperactivity/Imp.  1  0.94-1.07  0.98  0.91-1.05
ODD 1.18  0.91-1.53
Conduct Disorder  1.11  0.86-1.42
Nagelkerke  R2 0.127  0.128  0.31
Marijuana
Constant 0*  0*  0*
Age 1.90* 1.03-3.53 1.82† 0.83-3.56 1.68  0.79-3.59
Inattention 1.06 0.98-1.15 1.09† 0.99-1.19
Hyperactivity  /Imp.  1.01  0.95-1.07  0.98  0.92-1.06
ODD 0.93  0.71-1.21
Conduct Disorder  1.45*  1.02-2.07
Nagelkerke  R2 0.162  0.24  0.44
Other illegal  drugs
Constant  0.42  0.09  4811.88
Age 0.97  0.56-1.66  0.89  0.51-1.56  0.51  0.20-1.30
Inattention 1.05  0.95-1.16  1.05  0.94-1.16
Hyperactivity/Imp.  0.99  0.92-1.07  0.96  0.86-1.06
ODD 0.77  0.55-1.09
Conduct Disorder 1.95** 1.20-3.16
Nagelkerke  R2 0.001  0.04  0.49
Note. ODD = Oppositional deﬁant disorder; CI = conﬁdence interval; OR = odds ratio. †  < .10; * p < .05; ** p < .010.
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TLimitations  and  futures  directions
The  results  from  this  study  should  be  considered  in  the  con-
text  of  several  unique  study  features  and  limitations.  The
group  of  young  adults  with  ADHD  was  relatively  small  and
had  clinical  remission.  Therefore,  it  would  be  interesting
to  replicate  the  study  with  a  larger  sample.  In  addition,  all
of  the  participants  in  the  sample  with  ADHD  were  diagnosed
with  the  combined  type  from  the  DSM-IV,  so  generalization  of
the  results  should  generally  not  extend  beyond  this  subtype.
Especially  because  both  ADHD  subtypes  differs  signiﬁcantly
in  attention  and  in  state  and  trait  anxiety  (González-Castro,
Rodriguez,  Cueli,  García,  &  Alvarez-García,  2015).  Moreover,
comorbid  problems  were  reported  using  a  screening  mea-
sure.  These  results  should  be  replicated  using  instruments
to  establish  a  clinical/psychiatric  diagnostic.  In  this  study,
the  moderating  role  of  socio-environmental  risk  variables
was  not  examined  either,  such  as  parents’  educating  styles
t
p
cr  friends’  attitudes  towards  consumption  and  easy  access
o  drugs,  among  others.
Overall,  the  relevance  of  our  ﬁndings  consists  of  their
ontribution  to  underscoring  that  young  adults  with  an  ADHD
iagnosis  have  an  increased  risk  of  SU,  speciﬁcally  tobacco
nd  marijuana,  and  therefore  require  preventive  and  early
ntervention  efforts.  Comorbid  ADHD  and  SU  produce  sig-
iﬁcant  and  unique  treatment  challenges,  including  less
ikelihood  of  successful  treatment  completion,  a  longer  time
o  SU  recovery,  and  earlier  SU  relapse.  Unfortunately,  ADHD
edication  does  not  protect  the  individual  from  the  risk  of
U  (Molina  et  al.,  2013),  and  its  efﬁcacy  in  the  treatment  of
o-occurring  ADHD  and  SU  is  only  modest  (Cunill,  Castells,
obias,  &  Capellà,  2015),  which  suggests  the  need  to  iden-
ify  alternative  or  adjunct  approaches  to  substance  abuse
revention  and  ADHD  treatment.
Psychotherapeutic  intervention  in  addition  to  pharma-
ological  treatment  can  be  beneﬁcial.  Cognitive  behavioral
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herapy  may  be  of  particular  interest,  and  neurofeeedback
given  preliminary  evidence  suggesting  its  possible  efﬁcacy
n  adolescents  with  comorbid  ADHD  and  SU  (Thurstone,
iggs,  Salomonsen-Sautel,  &  MikulichGilbertson,  2010).
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